title: [Tuberculous meningitis: clinical, biological and x-ray computed tomographic comparison between patients with or without HIV infection].
abstract: OBJECTIVE
  Determine possible differences in clinical manifestations, laboratory findings and neuroimaging results in tuberculous meningitis patients with and without HIV infection.
  
  
  METHODS
  We retrospectively reviewed data of 38 patients with positive cerebrospinal fluid cultures for Mycobacterium tuberculosis who were hospitalized in 3 university hospitals in Paris over the last 11 years.
  
  
  RESULTS
  There were 24 HIV-infected patients and 14 without HIV infection. Mean CD4 lymphocyte count was 103 +/- 180/mm3 in the HIV group. Age (median age = 33 years for the HIV group vs. 53 for the non-HIV group), sex ratio (3 vs. 0.75), and prior history of tuberculosis (46% vs. 43%) were similar in both groups. Clinical presentation was similar for headache (83% in HIV group vs. 50% in non-HIV group; p = 0.02) and confusion (54% vs. 93% in non-HIV group p = 0.05). Serum natremia (mmol/l) (131 +/- 5 vs. 125 +/- 8; p = 0.024), white blood cell count (x 10(9)/l) (5.8 +/- 4.7 vs. 10.7 +/- 1.7; p = 0.37) and erythrocyte sedementation rate (mm/h) (68 +/- 34 vs. 31 +/- 35; p = 0.003) were significantly different in the 2 groups. Median cerebrospinal fluid findings were similar in the 2 groups: leukocytes (x 10(6)/l) (375 +/- 860 vs 218 +/- 250), glucose (mmol/l) (2.3 +/- 0.9 vs 2.7 +/- 1.9) and protein (g/l) (3.8 +/- 7.1 vs. 2.6 +/- 1.6). CT-scans of the brain were similar in the 2 groups. Mortality during hospitalization was similar (42% vs 36%; NS).
  
  
  CONCLUSIONS
  HIV infection appears to have little impact on the presentation of tuberculous meningitis.
authors.affiliation: Service de Maladies infectieuses et tropicales Hôpital Pitié-Salpêtrière, Paris.
authors.forename: P
authors.initials: P
authors.lastname: Bossi
authors.forename: O
authors.initials: O
authors.lastname: Reverdy
authors.forename: E
authors.initials: E
authors.lastname: Caumes
authors.forename: E
authors.initials: E
authors.lastname: Mortier
authors.forename: J L
authors.initials: JL
authors.lastname: Meynard
authors.forename: M C
authors.initials: MC
authors.lastname: Meyohas
authors.forename: J
authors.initials: J
authors.lastname: Cabane
authors.forename: J
authors.initials: J
authors.lastname: Frottier
authors.forename: F
authors.initials: F
authors.lastname: Bricaire
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications*; D018023:HIV Seronegativity; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D014390:Tuberculosis, Meningeal / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000209:etiology
chemical_list: D000995:Antitubercular Agents